Late Gastrointestinal and Hepatic Effects

  • M. M. Hudson
Part of the Pediatric Oncology book series (PEDIATRICO)


Childhood Cancer Graft Versus Host Disease Focal Nodular Hyperplasia Childhood Cancer Survivor Nodular Regenerative Hyperplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Donaldson SS, Jundt S, Ricour C, Sarrazin D, Lemerle J, Schweisguth O (1975) Radiation enteritis in children. A retrospective review, clinicopathologic correlation, and dietary management. Cancer 351167–1178Google Scholar
  2. 2.
    Chao N, Levine J, Horning SJ (1987) Retroperitoneal fibrosis following treatment for Hodgkin's disease. J Clin Oncol 5:231–232PubMedGoogle Scholar
  3. 3.
    Heyn R, Raney RB, Jr., Hays DM et al. (1992) Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol 10:614–623PubMedGoogle Scholar
  4. 4.
    Hughes LL, Baruzzi MJ, Ribeiro RC et al. (1994) Paratesticular rhabdomyosarcoma: delayed effects of multimodality therapy and implications for current management. Cancer 73:476–482PubMedGoogle Scholar
  5. 5.
    Kaplinsky C, Kornreich L, Tiomny E, Cohen IJ, Loven D, Zaizov R (1991) Esophageal obstruction 14 years after treatment for Hodgkin's disease. Cancer 68:903–905PubMedGoogle Scholar
  6. 6.
    Mahboubi S, Silber JH (1997) Radiation-induced esophageal strictures in children with cancer. Eur Radiol 7:119–122CrossRefPubMedGoogle Scholar
  7. 7.
    Papazian A, Capron JP, Ducroix JP, Dupas JL, Quenum C, Besson P (1983) Mucosal bridges of the upper esophagus after radiotherapy for Hodgkin's disease. Gastroenterology 84:1028–1031PubMedGoogle Scholar
  8. 8.
    Raney B Jr, Heyn R, Hays DM et al. (1993) Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study Committee. Cancer 71:2387–2394PubMedGoogle Scholar
  9. 9.
    Deeg HJ, Storb R, Thomas ED (1984) Bone marrow transplantation: a review of delayed complications. Br J Haematol 57:185–208PubMedGoogle Scholar
  10. 10.
    Fisher VL (1999) Long-term follow-up in hematopoietic stem-cell transplant patients. Pediatr Transplant 3[Suppl 1]:122–129CrossRefPubMedGoogle Scholar
  11. 11.
    Knapp AB CJ, Rappeport JM, Gollan JL (1987) Cirrhosis as a consequence of graft versus host disease. Gastroenterology 92:513–519PubMedGoogle Scholar
  12. 12.
    Locasciulli A, Bacigalupo A, van Lint MT et al. (1990) Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases. Bone Marrow Transplant 6:25–29PubMedGoogle Scholar
  13. 13.
    Locasciulli A, Gornati G, Tagger A et al. (1991) Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission. Blood 78:1619–1622PubMedGoogle Scholar
  14. 14.
    Locasciulli A, Testa M, Valsecchi MG et al. (1997) Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study. Blood 90:3799–3805PubMedGoogle Scholar
  15. 15.
    Paul IM, Sanders J, Ruggiero F, Andrews T, Ungar D, Eyster ME (1999) Chronic hepatitis C virus infections in leukemia survivors: prevalence, viral load, and severity of liver disease. Blood 93:3672–3677PubMedGoogle Scholar
  16. 16.
    Socie G, Stone JV, Wingard JR et al. (1999) Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 341:14–21PubMedGoogle Scholar
  17. 17.
    Strickland DK, Jenkins JJ, Hudson MM (2001) Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer. J Pediatr Hematol Oncol 23:527–529PubMedGoogle Scholar
  18. 18.
    Castellino S, Lensing S, Riely CA et al. (2004) The epidemiology of chronic hepatitis C infection in survivors of childhood cancer — an update of the St. Jude Children's Research Hospital hepatitis C seropositive cohort. Blood 103:2460–2466CrossRefPubMedGoogle Scholar
  19. 19.
    Yau JC, Zander AR, Srigley JR et al. (1986) Chronic graftversushost disease complicated by micronodular cirrhosis and esophageal varices. Transplantation 41:129–130PubMedGoogle Scholar
  20. 20.
    Strasser SI, Sullivan KM, Myerson D et al. (1999) Cirrhosis of the liver in long-term marrow transplant survivors. Blood 93:3259–3266PubMedGoogle Scholar
  21. 21.
    Fajardo L (1989) Radiation-induced pathology of the alimentary tract. In: Whitehead R (ed) Gastrointestinal and oesophageal pathology. Churchill Livingstone, EdinburghGoogle Scholar
  22. 22.
    Shulman H (1990) Pathology of chronic graft-vs.-host disease. In: Burakoff S (ed) Graft-vs-host disease immunology, pathophysiology and treatment. Dekker, New YorkGoogle Scholar
  23. 23.
    Bhatia S, et al. (2003) High risk of second malignant neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group. J Clin Oncol (in press)Google Scholar
  24. 24.
    Metayer C, Lynch CF, Clarke EA et al. (2000) Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18:2435–2443PubMedGoogle Scholar
  25. 25.
    Swerdlow AJ, Barber JA, Hudson GV et al. (2000) Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 18:498–509PubMedGoogle Scholar
  26. 26.
    Roswit B (1974) Complications of radiation therapy: the alimentary tract. Semin Roentgenol 9:51–63CrossRefPubMedGoogle Scholar
  27. 27.
    Berthrong M, Fajardo LF (1981) Radiation injury in surgical pathology. Part II. Alimentary tract. Am J Surg Pathol 5:153–178PubMedGoogle Scholar
  28. 28.
    Localio SA, Stone A, Friedman M (1969) Surgical aspects of radiation enteritis. Surg Gynecol Obstet 129:1163–1172PubMedGoogle Scholar
  29. 29.
    Emami B, Lyman J, Brown A et al. (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122PubMedGoogle Scholar
  30. 30.
    Donaldson SS, Glatstein E, Rosenberg SA, Kaplan HS (1976) Pediatric Hodgkin's disease. II. Results of therapy. Cancer 37:2436–2447PubMedGoogle Scholar
  31. 31.
    Tefft M (1977) Radiation related toxicities in National Wilms'Tumor Study Number 1. Int J Radiat Oncol Biol Phys 2:455–463PubMedGoogle Scholar
  32. 32.
    Seaman WB, Ackerman LV (1957) The effect of radiation on the esophagus; a clinical and histologic study of the effects produced by the betatron. Radiology 68:534–541PubMedGoogle Scholar
  33. 33.
    Lepke RA, Libshitz HI (1983) Radiation-induced injury of the esophagus. Radiology 148:375–378PubMedGoogle Scholar
  34. 34.
    Goldstein HM, Rogers LF, Fletcher GH, Dodd GD (1975) Radiological manifestations of radiation-induced injury to the normal upper gastrointestinal tract. Radiology 117:135–140PubMedGoogle Scholar
  35. 35.
    Orringer MB, Sloan H (1978) Monilial esophagitis: an increasingly frequent cause of esophageal stenosis? Ann Thorac Surg 26:364–374PubMedGoogle Scholar
  36. 36.
    Simson JN, Kinder RB, Isaacs PE, Jourdan MH (1985) Mucosal bridges of the oesophagus in Candida oesophagitis. Br J Surg 72:209–210PubMedGoogle Scholar
  37. 37.
    Horwich A, Lokich JJ, Bloomer WD (1975) Doxorubicin, radiotherapy, and oesophageal stricture. Lancet 2:561–562CrossRefGoogle Scholar
  38. 38.
    Newburger PE, Cassady JR, Jaffe N (1978) Esophagitis due to adriamycin and radiation therapy for childhood malignancy. Cancer 42:417–423PubMedGoogle Scholar
  39. 39.
    Phillips TL, Fu KK (1976) Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues. Cancer 37[Suppl 2]:1186–1200PubMedGoogle Scholar
  40. 40.
    Boal DK, Newburger PE, Teele RL (1979) Esophagitis induced by combined radiation and adriamycin. AJR Am J Roentgenol 132:567–570PubMedGoogle Scholar
  41. 41.
    Tefft M, Lattin PB, Jereb B et al. (1976) Acute and late effects on normal tissues following combined chemo-and radiotherapy for childhood rhabdomyosarcoma and Ewing's sarcoma. Cancer 37[Suppl 2]:1201–1217PubMedGoogle Scholar
  42. 42.
    Meyers PA, Potter VP, Wollner N, Exelby P (1985) Bowel perforation during initial treatment for childhood non-Hodgkin's lymphoma. Cancer 56:259–261PubMedGoogle Scholar
  43. 43.
    Wobbes T, Verschueren RC, Lubbers EJ, Jansen W, Paping RH (1984) Surgical aspects of radiation enteritis of the small bowel. Dis Colon Rectum 27:89–92PubMedGoogle Scholar
  44. 44.
    Ritchey ML, Kelalis PP, Breslow N et al. (1992) Surgical complications after nephrectomy for Wilms’ tumor. Surg Gynecol Obstet 175:507–514PubMedGoogle Scholar
  45. 45.
    Jockovich M, Mendenhall NP, Sombeck MD, Talbert JL, Copeland EM 3rd, Bland KI (1994) Long-term complications of laparotomy in Hodgkin's disease. Ann Surg 219:615–621; discussion 621–614PubMedGoogle Scholar
  46. 46.
    Hays DM, Ternberg JL, Chen TT et al. (1986) Postsplenectomy sepsis and other complications following staging laparotomy for Hodgkin's disease in childhood. J Pediatr Surg 21:628–632PubMedGoogle Scholar
  47. 47.
    Hays DM, Ternberg JL, Chen TT et al. (1984) Complications related to 234 staging laparotomies performed in the Intergroup Hodgkin's Disease in Childhood study. Surgery 96:471–478PubMedGoogle Scholar
  48. 48.
    Kaiser CW (1981) Complications from staging laparotomy for Hodgkin disease. J Surg Oncol 16:319–325PubMedGoogle Scholar
  49. 49.
    Smith IE, Peckham MJ, McElwain TJ, Gazet JC, Austin DE (1977) Hodgkin's disease in children. Br J Cancer 36:120–129PubMedGoogle Scholar
  50. 50.
    Green DM, Ghoorah J, Douglass HO Jr et al. (1983) Staging laparotomy with splenectomy in children and adolescents with Hodgkin's disease. Cancer Treat Rev 10:23–38CrossRefGoogle Scholar
  51. 51.
    Lanzkowsky P, Shende A, Karayalcin G, Aral I (1976) Staging laparotomy and splenectomy: treatment and complications of Hodgkin's disease in children. Am J Hematol 1:393–404PubMedGoogle Scholar
  52. 52.
    Filler RM, Jaffe N, Cassady JR, Traggis DG, Vawter GF (1975) Experience with clinical and operative staging of Hodgkin's disease in children. J Pediatr Surg 10:321–328CrossRefPubMedGoogle Scholar
  53. 53.
    Cohen IT, Higgins GR, Powars DR, Hays DM (1977) Staging laparotomy for Hodgkin's disease in children. Evaluation of the technique. Arch Surg 112:948–951PubMedGoogle Scholar
  54. 54.
    Bell MJ, Land VJ, Ternberg JL (1977) Staging laparotomy for Hodgkin's disease in children. Am J Surg 133:582–583CrossRefPubMedGoogle Scholar
  55. 55.
    Zinchke H, Segura JW (1975) Ureterosigmoidostomy: critical review of 173 cases. J Urol 113:324–327PubMedGoogle Scholar
  56. 56.
    Bristol JB, Williamson RC (1981) Ureterosigmoidostomy and colon carcinogenesis. Science 214:351PubMedGoogle Scholar
  57. 57.
    Gittes RF (1986) Carcinogenesis in ureterosigmoidostomy. Urol Clin North Am 13:201–205PubMedGoogle Scholar
  58. 58.
    McDonald GB, Sullivan KM, Schuffler MD, Shulman HM, Thomas ED (1981) Esophageal abnormalities in chronic graft-versus-host disease in humans. Gastroenterology 80:914–921PubMedGoogle Scholar
  59. 59.
    McDonald GB, Sullivan KM, Plumley TF (1984) Radiographic features of esophageal involvement in chronic graft-vs.-host disease. AJR Am J Roentgenol 142:501–506PubMedGoogle Scholar
  60. 60.
    Screening for colorectal cancer (2004). United States Preventive Services Task Force. Available at: September 28Google Scholar
  61. 61.
    Smith RA, Cokkinides V, Eyre HJ (Jan–Feb 2004) American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 54(1): 41–52PubMedGoogle Scholar
  62. 62.
    Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. CureSearch Children's Oncology Group. March 2004Google Scholar
  63. 63.
    Patrick RS, McGee JOD (1980) Biopsy pathology of the liver. Chapman Hall, LondonGoogle Scholar
  64. 64.
    Shulman HM, Sullivan KM, Weiden PL et al. (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69:204–217CrossRefPubMedGoogle Scholar
  65. 65.
    Tsoi MS, Storb R, Jones E et al. (1978) Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man. J Immunol 120:1485–1492PubMedGoogle Scholar
  66. 66.
    Blatt J, Olshan A, Gula MJ, Dickman PS, Zaranek B (1992) Second malignancies in very-long-term survivors of childhood cancer. Am J Med 93:57–60CrossRefPubMedGoogle Scholar
  67. 67.
    Ingold JA RG, Kaplan HS, Bagshaw MA (1965) Radiation hepatitis. Am J Roentgenol 93:200–208Google Scholar
  68. 68.
    Jirtle RL, Alati T (1990) Radiation sensitivity of the liver. Adv Radiat Biol 14:269–311Google Scholar
  69. 69.
    Tefft M, Jaffe MA (1971) Irradiation of the liver in children: acute effects enhanced by concomitant chemotherapeutic administration. Am J Roentgenol Rad Ther Nucl Med 111:165–173Google Scholar
  70. 70.
    Tefft M MA, Das L, Vawter GF, Filler RM (1970) Irradiation of the liver in children: review of the experience in the acute and chronic phases, and in the intact normal and partially resected. Am J Roentgenol Rad Ther Nucl Med 108:365–385Google Scholar
  71. 71.
    Kun LE, Camitta BM (1978) Hepatopathy following irradiation and adriamycin. Cancer 42:81–84PubMedGoogle Scholar
  72. 72.
    Bhanot P, Cushing B, Philippart A, Das L, Farooki Z (1979) Hepatic irradiation and adriamycin cardiotoxicity. J Pediatr 95:561–563PubMedGoogle Scholar
  73. 73.
    Johnson FL (1982) Hepatopathy following irradiation and chemotherapy for Wilms’ tumor. Am J Pediatr Hematol Oncol 4:217–221PubMedGoogle Scholar
  74. 74.
    Flentje M, Weirich A, Potter R, Ludwig R (1994) Hepatotoxicity in irradiated nephroblastoma patients during postoperative treatment according to SIOP9/GPOH. Radiother Oncol 31:222–228CrossRefPubMedGoogle Scholar
  75. 75.
    Barnard JA MG, Neblett WW, Gray G, Ghishan FK (1986) Noncirrhotic portal fibrosis after Wilms’ tumor therapy. Gastroenterology 90:1054–1056PubMedGoogle Scholar
  76. 76.
    Perry M (1992) Chemotherapeutic agents and hepatotoxicity. Semin Oncol 19:551–565PubMedGoogle Scholar
  77. 77.
    Locasciulli A, Vergani GM, Uderzo C et al. (1983) Chronic liver disease in children with leukemia in long-term remission. Cancer 52:1080–1087PubMedGoogle Scholar
  78. 78.
    Weber BL, Tanyer G, Poplack DG et al. (1987) Transient acute hepatotoxicity of high-dose methotrexate therapy during childhood. NCI Monogr 5:207–212PubMedGoogle Scholar
  79. 79.
    Bessho F, Kinumaki H, Yokota S, Hayashi Y, Kobayashi M, Kamoshita S (1994) Liver function studies in children with acute lymphocytic leukemia after cessation of therapy. Med Pediatr Oncol 23:111–115PubMedGoogle Scholar
  80. 80.
    Ballauff A, Krahe J, Jansen B, Ross RS, Roggendorf H, Havers W (1999) Chronic liver disease after treatment of malignancies in children. Klin Pediatr 211:49–52Google Scholar
  81. 81.
    Lascari AD, Givler RL, Soper RT, Hill LF (1968) Portal hypertension in a case of acute leukemia treated with antimetabolites for ten years. N Engl J Med 279:303–306PubMedGoogle Scholar
  82. 82.
    Ruymann FB, Mosijczuk AD, Sayers RJ (1977) Hepatoma in a child with methotrexate-induced hepatic fibrosis. JAMA 238:2631–2633CrossRefPubMedGoogle Scholar
  83. 83.
    Nesbit M, Krivit W, Heyn R, Sharp H (1976) Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems. Cancer 37[Suppl 2]:1048–1057PubMedGoogle Scholar
  84. 84.
    Einhorn M DI (1964) Hepatotoxicity of mercaptopurine. JAMA 188:102–106Google Scholar
  85. 85.
    Green DM, Norkool P, Breslow NE, Finklestein JZ, D'Angio GJ (1990) Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divideddose schedules: a report from the National Wilms’ Tumor Study. J Clin Oncol 8:1525–1530PubMedGoogle Scholar
  86. 86.
    Raine J, Bowman A, Wallendszus K, Pritchard J (1991) Hepatopathy-thrombocytopenia syndrome — a complication of dactinomycin therapy for Wilms’ tumor: a report from the United Kingdom Childrens Cancer Study Group. J Clin Oncol 9:268–273PubMedGoogle Scholar
  87. 87.
    Parker D, Bate CM, Craft AW, Graham-Pole J, Malpas JS, Stansfeld AG (1980) Liver damage in children with acute leukaemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy. Cancer Chemother Pharmacol 4:121–127CrossRefPubMedGoogle Scholar
  88. 88.
    McIntosh S DD, O'Brien RT, Pearson HA (1977) Methotrexate hepatotoxicity in children with leukemia. J Pediatr 90:1019–1021PubMedGoogle Scholar
  89. 89.
    Topley JM, Squier MV, Chessells JM (1979) Hepatotoxicity in the treatment of acute lymphoblastic leukemia. Med Pediatr Oncol 7:393–399PubMedGoogle Scholar
  90. 90.
    Hutter RVP, Tan CTC, Murphy ML, Chowdhury M (1960) Hepatic fibrosis in children with acute leukemia: a complication of therapy. Cancer 13:288–307PubMedGoogle Scholar
  91. 91.
    Colsky J, Warren TN (1955) Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists. Arch Pathol Lab Med 59:198–206Google Scholar
  92. 92.
    Hersh EM WV, Henderson ES, Freireich E (1966) Hepatotoxic effects of methotrexate. Cancer 19:600–606PubMedGoogle Scholar
  93. 93.
    Farthing MJG, Sloane JP (1982) Liver disease after bone marrow transplantation. Gut 23:465–474PubMedGoogle Scholar
  94. 94.
    Shulman HM, McDonald DB (1984) Liver disease after marrow transplantation. In: Sale GE, Shulman HM (eds) The pathology of bone marrow transplantation. Year Book Medical Publishers, Chicago, pp 104–135Google Scholar
  95. 95.
    Zecca M, Prete A, Rondelli R et al. (2002) Chronic graftversushost disease in children: incidence, risk factors, and impact on outcome. Blood 100:1192–1200CrossRefPubMedGoogle Scholar
  96. 96.
    Sullivan KM, Agura E, Anasetti C et al. (1991) Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28:250–259PubMedGoogle Scholar
  97. 97.
    Seeff LB, Koff RS (1986) Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection. Semin Liver Dis 6:11–22PubMedGoogle Scholar
  98. 98.
    Strickland DK, Riely CA, Patrick CC et al. (2000) Hepatitis C infection among survivors of childhood cancer. Blood 95:3065–3070PubMedGoogle Scholar
  99. 99.
    Fink FM, Hocker-Schulz S, Mor W et al. (1993) Association of hepatitis C virus infection with chronic liver disease in paediatric cancer patients. Eur J Pediatr 152:490–492CrossRefPubMedGoogle Scholar
  100. 100.
    Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL (1999) Persistence of viremia and the importance of longterm follow-up after acute hepatitis C infection. Hepatology 29:908–914CrossRefPubMedGoogle Scholar
  101. 101.
    Arico M, Maggiore G, Silini E et al. (1994) Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 84:2919–2922PubMedGoogle Scholar
  102. 102.
    Cesaro S, Rossetti F, de Moliner L, Crivellaro C, Zanesco L, Bortolotti F (1994) Interferon for chronic hepatitis C in patients cured of malignancy. Eur J Pediatr 153:659–662PubMedGoogle Scholar
  103. 103.
    Cesaro S, Petris MG, Rossetti F et al. (1997) Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 90:1315–1320PubMedGoogle Scholar
  104. 104.
    Locasciulli A, Alberti A, Barbieri R et al. (1983) Evidence of non-A, non-B hepatitis in children with acute leukemia and chronic liver disease. Am J Dis Child 137:354–356PubMedGoogle Scholar
  105. 105.
    Locasciulli A, Bacigalupo A, Vanlint MT et al. (1991) Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. Transplantation 52:315–318PubMedGoogle Scholar
  106. 106.
    Locasciulli A, Cavalletto D, Pontisso P et al. (1993) Hepatitis C virus serum markers and liver disease in children with leukemia during and after chemotherapy. Blood 82:2564–2567PubMedGoogle Scholar
  107. 107.
    Locasciulli A, Pontisso P, Cavalletto D et al. (1994) Evidence against the role of hepatitis C virus in severe liver damage occurring early in the course of acute leukemia in children. Leuk Lymph 13:119–122Google Scholar
  108. 108.
    Locasciulli A, Testa M, Pontisso P et al. (1997) Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 90:4628–4633PubMedGoogle Scholar
  109. 109.
    Locasciulli A, Testa M, Pontisso P et al. (1997) Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 19:237–240CrossRefPubMedGoogle Scholar
  110. 110.
    Lucidarme D DF, Arpurt J et al. (1997) Natural history of hepatitis C: age at the time of transfusion might be an important predictive factor of progression to cirrhosis. Gastroenterology 112:A361Google Scholar
  111. 111.
    Swilley S SD, Davila R, Levstik M, Ribeiro R, Hudson MM (2002) Hepatitis C infection during treatment for childhood cancer: pitfalls in diagnosis and management. Med Pediatr Oncol 39:58–59CrossRefPubMedGoogle Scholar
  112. 112.
    Vogt M, Lang T, Frosner G et al. (1999) Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 341:866–870CrossRefPubMedGoogle Scholar
  113. 113.
    Neilson JR, Harrison P, Skidmore SJ, King JA, Collingham KE, Milligan DW (1996) Chronic hepatitis C in long term survivors of haematological malignancy treated in a single centre. J Clin Pathol 49:230–232PubMedGoogle Scholar
  114. 114.
    Gigliotti AR, Fioredda F, Giacchino R (2003) Hepatitis B and C infection in children undergoing chemotherapy or bone marrow transplantation. J Pediatr Hematol Oncol 25:184–192CrossRefPubMedGoogle Scholar
  115. 115.
    Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825–832CrossRefPubMedGoogle Scholar
  116. 116.
    Goedert JJ, Eyster ME, Lederman MM et al. (2002) Endstage liver disease in persons with hemophilia and transfusion-associated infections. Blood 100:1584–1589PubMedGoogle Scholar
  117. 117.
    Franchini M, Rossetti G, Tagliaferri A et al. (2001) The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders. Blood 98:1836–1841CrossRefPubMedGoogle Scholar
  118. 118.
    Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH (2000) Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132:296–305PubMedGoogle Scholar
  119. 119.
    Mahmoud H, Schell M, Pui CH (1991) Cholelithiasis after treatment for childhood cancer. Cancer 67:1439–1442PubMedGoogle Scholar
  120. 120.
    Chu WC, Roebuck DJ (2003) Nodular regenerative hyperplasia of the liver simulating metastases following treatment for bilateral Wilms tumor. Med Pediatr Oncol 41:85–87CrossRefPubMedGoogle Scholar
  121. 121.
    Wanless IR (1990) Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 11:787–797PubMedGoogle Scholar
  122. 122.
    Kumagai H, Masuda T, Oikawa H, Endo K, Endo M, Takano T (2000) Focal nodular hyperplasia of the liver: direct evidence of circulatory disturbances. J Gastroenterol Hepatol 15:1344–1347CrossRefPubMedGoogle Scholar
  123. 123.
    Bouyn CI, Leclere J, Raimondo G et al. (2003) Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 97:3107–3113CrossRefPubMedGoogle Scholar
  124. 124.
    Brisse H, Servois V, Bouche B et al. (2000) Hepatic regenerating nodules: a mimic of recurrent cancer in children. Pediatr Radiol 30:386–393CrossRefPubMedGoogle Scholar
  125. 125.
    Halonen P, Mattila J, Ruuska T, Salo MK, Makipernaa A (2003) Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings. Med Pediatr Oncol 40:148–154CrossRefPubMedGoogle Scholar
  126. 126.
    Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T (1997) Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. J Hepatol 26:312–324CrossRefPubMedGoogle Scholar
  127. 127.
    Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T (1997) Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology 25:63–70PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • M. M. Hudson

There are no affiliations available

Personalised recommendations